相关实验视频
Updated: Sep 11, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
患者体验和改善机会在自行管理,大容量皮下输液在家中
Chris Franzese1,2, James Hawthorne1,3, Dimos Katsaros1,4
1Matchstick LLC, Boonton, NJ, USA.
Patient preference and adherence
|August 19, 2025
概括
患者更喜欢大容量皮下自给药 (LVSC),而不是像皮下免疫球蛋白 (SCIg) 这样的生物治疗药物. 然而,目前的SCIg设备在准备,管理和管理方面存在挑战,突出需要改进交付设备设计.
科学领域:
- 生物制药物供应提供.
- 患者自给自行使用.
- 药物输送装置设计 药物输送装置设计
背景情况:
- 皮下 (SC) 给药是生物治疗的首选途径.
- 行业越来越关注大批量SC (LVSC) 开发.
- 有限的文献存在于现实世界的LVSC自我管理实践.
研究的目的:
- 探索用户对LVSC输送设备设计的需求和偏好.
- 识别当前LVSC自我管理实践中的挑战.
- 为未来的LVSC治疗和设备开发提供信息.
主要方法:
- 患者在家中自行服用SCIg的远程民族学研究.
- 参与者通过视频和照片记录了准备和输注过程.
- 分析了关于疾病,输液和设备的主题和情绪的定性数据.
主要成果:
- 11名患有原发性免疫缺陷疾病 (PIDD) 的患者完成了这项研究.
- 参与者普遍更喜欢SC管理,但报告了疼痛点.
- 挑战包括药物管理,储存,设备故障排除,准备和管理.
结论:
- 尽管面临当前的挑战,但患者更喜欢在家进行LVSC的管理.
- 洞察力为LVSC自我管理设备设计提供用户需求的信息.
- 这些发现可以改进现有的设备,并预测新的LVSC治疗开发中的障碍.
相关概念视频
Routes of Drug Administration: Parenteral
2.1K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K
One-Compartment Open Model for IV Bolus Administration: General Considerations
316
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
316
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
137
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
137
Drug Delivery: Parenteral Route
831
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
831
Insulin Formulations: Types and Delivery
270
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
270
Two-Compartment Open Model: IV Bolus Administration
697
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
697

